Related by context. All words. (Click for frequent words.) 63 Evaluation Program CTEP 61 Group B CALGB 60 Bowel Project NSABP 59 CALGB 59 Damaging Tornadoes Reported 59 Group RTOG 58 HCV SPRINT 58 journal BioMed 58 PRESEPT 58 NCCTG N# 58 Menopause Society NAMS 57 Bellemeade Blvd 57 Brain Tumor Registry 57 NCCTG 57 TG MV 57 Breast Cancer Intergroup 57 CHAMPION PCI 57 Edge STudy 57 Multicentre 56 Pre RELAX AHF 56 Group ECOG 56 SWOG 56 Mandolin Cafe Tacoma 56 Gynecologic Oncology Group 56 RECORD1 56 CARE HF 56 Phase III multicenter 55 treatment naïve genotype 55 NSABP B 55 Central Cancer Registries 55 randomized multicenter trial 55 BRIM3 55 Screening Trial DMIST 55 AIR2 Trial 55 BRIM2 55 Trial PCPT 54 EchoCRT 54 Koreaâ 54 blinded randomized placebo controlled 54 Screening Trial 54 ExTRACT TIMI 54 AVAiL 54 Phase Ib II 54 CAMMS# 54 BCIRG 54 phase Ib 54 Clinical Antipsychotic Trials 54 prospective observational cohort 54 Liraglutide Effect 54 ICON7 54 NSABP 54 Bayer HealthCare Onyx Pharmaceuticals 54 Tuberculosis Vaccine 54 ACRIN 54 Dana-Farber/Children s Hospital 54 Improvement NCA CASI 54 AVADO 54 Colby WA #-# 54 Carotid Revascularization Endarterectomy vs. 54 REVIVE Diabetes 54 Cooperative Oncology 54 American narcoterrorism operatives 54 tramiprosate Alzhemed TM 54 Phase III VISTA 54 evaluating tivozanib 54 HCV RESPOND 2 54 Diagnosis DCTD 54 Radiation Therapy Oncology 53 ACOSOG Z# 53 Dialysis Outcomes 53 National Surgical Adjuvant 53 ongoing Phase 1b 53 Naive Patients 53 phase III ACCLAIM 53 ongoing Phase IIIb 53 multicenter Phase II 53 Wales Chron Bangor 53 evaluating Nexavar 53 Ovarian PLCO Cancer 53 Sorafenib HCC Assessment 53 Tribune Willmar Minn. 53 REUTERS Chip 53 Association www.ncahlc.org 53 Digital Mammographic Imaging 53 Easily Manage Your 53 Hormone Refractory Prostate Cancer 53 galiximab 53 multicenter randomized clinical 53 relapsed MM 53 ACTEMRA TM 53 journal Gynecologic Oncology 53 randomized controlled multicenter 53 registrational Phase 53 EOquin TM 53 Prostate Cancer Prevention 53 Initiated Phase 53 Wisconsin Sleep Cohort 52 Prostate Lung Colorectal 52 Prospective Multicenter 52 Cellular Therapies 52 multicenter multinational 52 randomized multicenter 52 RIO Lipids 52 Battelle Biomedical 52 neoadjuvant treatment 52 BARI 2D 52 controlled multicenter 52 retrospective cohort 52 metastatic GIST 52 Randomized Evaluation 52 Intervention Trial 52 Val HeFT 52 Melora B. 52 phase IIb study 52 brivaracetam 52 Medidata Developer 52 http:/www.wctrib.com 52 Spine Patient Outcomes 52 metastatic neuroendocrine tumors 52 recurrent glioblastoma multiforme 52 PCI ExTRACT TIMI 52 Phase 1b trial 52 RE LY ® 52 multicentre randomized 52 CryoSeal System 52 fosbretabulin 52 prospective observational 52 sorafenib tablets 51 Trandolapril 51 relapsing remitting MS RRMS 51 PRECiSE 51 Randomized Controlled 51 SABCS 51 EVEREST II 51 riociguat 51 Quadra FNX employs 51 budesonide MMX Phase III 51 NO# [002] 51 Arkansas Woodcarvers Club 51 Synergex serves 51 Phase Ib clinical 51 longitudinal cohort study 51 randomized Phase III 51 dose escalation phase 51 EORTC 51 receptor tyrosine kinase inhibitor 51 Oral Fingolimod 51 treatment naive genotype 51 Therapeutics START 51 ZACTIMA 51 GetGoal Phase III 51 Dr. Randy Heysek 51 observational cohort study 51 metastatic HRPC 51 CTAP# Capsules 51 underwent surgical resection 51 CLL8 51 prospective multicentre 51 Allovectin 7 ® 51 viral kinetic 51 EOquin TM phase 51 NICE SUGAR 51 CHARISMA trial 51 GW# [003] 51 MGd 51 Phase IIIb 51 neratinib 51 Randomized Phase II 51 multicenter randomized 51 label multicenter 51 Advanced Melanoma 51 Group NCIC CTG 51 Mineral Belt CMB 51 # BHL 51 malignant mesothelioma Alfacell 51 GELA 51 pivotal bioequivalence 51 ENESTnd 51 #-# amnh.org 51 TMC# C# 51 erlotinib Tarceva ® 51 Bowel Project 51 stage IIIb IV 51 STRIDE PD 51 TEMSO 51 ELCAP 51 Multiethnic Study 51 CALERIE 51 Accessed #/#/# [001] 51 multicenter phase 51 multicenter 51 MAGE A3 ASCI 51 BR.# 51 investigational protease inhibitor 51 papillary renal cell carcinoma 51 Tumor Response 51 forodesine 50 coinfected patients 50 multicenter Phase 50 multicentre study 50 evaluating carfilzomib 50 Prospective Randomized 50 Tom Cherveny West 50 Beach Diet Supercharged 50 randomized discontinuation trial 50 Nonprofit PetSmart Charities 50 prospective multicenter 50 multicentric 50 Felony Court Br. 50 HER2 positive metastatic breast 50 Research Councils CCLRC 50 randomized Phase 2b 50 Aflibercept 50 thorough QT 50 Randomized Phase 50 Estimated Minimum 50 TRITON TIMI 50 recurrent metastatic 50 LUX Lung 50 Teriflunomide 50 Multicenter 50 Xelox 50 Valley Bancorp NOVB 50 Phase Ib study 50 Complications Trial 50 evaluating REVLIMID 50 evaluating Actimmune 50 RE LY 50 HGS ETR2 50 include ColorectAlert TM 50 crizotinib PF # 50 Multicenter Automatic Defibrillator Implantation 50 phase IIa clinical 50 ICAEL 50 Study ADCS 50 Phase 1a clinical 50 Pooled Analysis 50 phase IIa 50 placebo controlled Phase III 50 nucleoside naive 50 Kahalalide F 50 designated HVTN 50 prospective observational studies 50 Griffith Mortuary 50 Blinatumomab 50 prospective randomized placebo 50 YONDELIS 50 Exact JobBOSS Exact 50 prospective nonrandomized 50 phase IIb 50 Quinsigamond Ave 50 Cohort Consortium 50 Denufosol 50 Atypical Hemolytic Uremic Syndrome 49 Enzastaurin 49 randomized Phase IIb 49 Gastric Cancer 49 Vaccine Shows Promise 49 BZA CE 49 Asthma Intervention 49 blinded randomized 49 Lymphocytic 49 KILLARNEY HOUSE 49 Genes Discovered 49 HYVET 49 Cloretazine ® 49 IMiDs ® compound 49 dose escalation trial 49 phase IIb clinical 49 Kissei Pharmaceuticals 49 controlled dose escalation 49 multicenter randomized controlled 49 Neoadjuvant 49 pan HDAC inhibitor 49 ISPO institute 49 By Gretchen Schlosser 49 YONDELIS R 49 Chandler Newberger 49 INSPIRE Trial Phase III 49 Study Evaluating 49 Sawn Lake heavy 49 GAMMAGARD 49 ConclusionThis 49 sunitinib Sutent ® 49 APPRAISE 49 refractory chronic lymphocytic 49 essential thrombocythemia ET 49 randomized controlled Phase 49 TAXUS ATLAS 49 ER CHOP 49 Cancer Incidence Mortality 49 BCR ABL inhibitor 49 Common Toxicity Criteria 49 VADT 49 advanced metastatic renal 49 biliary tract cancer 49 Media Organisation SEEMO 49 Practice Patterns 49 AVOREN 49 ToGA 49 Jakarta Jl 49 cisplatin gemcitabine 49 double blinded randomized 49 Aplidin R 49 pharmacokinetic pharmacodynamic 49 HIV HCV coinfected 49 Fraser WFT 49 abacavir Ziagen 49 Whitehall Twp 49 Pediatric Orthopaedic Society 49 Wales Argus Newsdesk 49 symptomatic BPH 49 Folfox 49 COPERNICUS 49 Miley Cyrus rapper Kanye 49 Patient Oriented 49 antiretroviral naïve 49 Teamsters Laborers International 49 Asheboro Swimming Pool 49 ELACYT 49 MetaBank MetaBank West 49 EGFR HER2 49 paclitaxel cisplatin 49 prospective longitudinal 49 CLARITY study 49 asymptomatic metastatic 49 substudy 49 Tarceva TM 49 Sipuleucel T 49 multicenter placebo controlled 49 Volta Greater Accra 49 Women Ischemia Syndrome 49 Garret Felder 49 Lacambra Sisters Filipino 49 undergoing androgen deprivation 49 TO AVOID PREGNANCY WHILE 49 multicenter clinical 49 surpassing MRSA infections 49 Borate Hills Projects 49 CCX# B 48 EURIDIS 48 PLCO 48 Phase IIIb clinical 48 enzastaurin 48 clinically evaluable 48 CIMZIA TM certolizumab pegol 48 Complicated Skin 48 ABSORB trial 48 placebo controlled Phase 48 TRO# 48 double blinded placebo 48 subanalysis 48 Velcade bortezomib 48 BARACLUDE ® 48 Stenting Trial CREST 48 doxorubicin cyclophosphamide 48 heFH 48 meta analysis pooling 48 multicenter prospective 48 Genome Sequencing Centers 48 ENGAGE AF TIMI 48 Temps soar 48 Antiepileptic Drug Pregnancy Registry 48 tarenflurbil 48 Phase IIIb study 48 Peginterferon 48 Psychologist Clinical 48 mertansine 48 placebo controlled dose escalation 48 MADIT CRT trial 48 undergone radical prostatectomy 48 Andrew Forgrave DPW 48 Sneaky Chef Missy 48 ECASS 48 Shore Rape Crisis 48 axitinib 48 gefitinib Iressa 48 placebo controlled clinical 48 Safinamide 48 ROCKET AF 48 dexamethasone Decadron 48 recurrent malignant glioma 48 http:/www.nctimes.com 48 ADXS# 48 WebLogic Log 48 assessing T DM1 48 Ocular Hypertension Treatment 48 mcg albinterferon alfa 2b 48 Pirfenidone 48 Genasense ® 48 Screenings Offered 48 Amrubicin 48 Linda Vanderwerf West 48 Tesmilifene 48 prospective randomized multicenter 48 Minneapolis WorkForce 48 requiring Asthmatx 48 GOUT 48 placebo controlled clinical trials 48 Pivotal Trial 48 BOLDER II 48 Greenville SC Michelin 48 placebo controlled multicenter 48 GSK# [001] 48 Expert Collision Repair 48 Burntsand operates 48 mITT population 48 Randomized Study 48 teriflunomide 48 docetaxel Taxotere ® 48 GENASIS 48 Nasdaq CSBC 48 docetaxel Taxotere R 48 Pardee Rehab 48 irinotecan cisplatin 48 Multicenter Randomized 48 thalidomide Thalomid 48 farletuzumab 48 Koreaā 48 dose escalation clinical 48 BMS # 48 Autologous Stem Cell Transplantation 48 Ocrelizumab 48 metastatic pancreatic 48 Texas WorkForce Corsicana 48 Severe Storms Rip 48 nonmetastatic prostate cancer 48 multicenter randomized Phase III 48 Breast Exams 48 Phase 2b monotherapy 48 NCIC Clinical Trials 48 Alzheimer Disease Cooperative 48 Non Alcoholic Steatohepatitis 48 mapatumumab 48 CALGB # [002] 48 FOLFIRI chemotherapy 48 Improve Diagnosis 48 Africa SAMEA 48 TITLE Auctions 48 dose escalation Phase 48 Economic Integration CABEI 48 Island MidWeek 48 DEB# 48 Quinamed 48 advanced hepatocellular carcinoma 48 Bev Llorente 48 multicenter study 48 Subgroup analysis 48 Xanafide 48 EMPHASIS HF trial 47 Productions Shadowline 47 HEIDENHAIN CORPORATION 47 Portage Path Akron 47 INCB# [003] 47 TWISTED BULL 47 Nexavar sorafenib 47 Placebo Controlled Trial 47 elotuzumab 47 recurrent glioma 47 Analytical Method 47 demonstrated antitumor activity 47 XIENCE V Stent System 47 trials RCTs 47 Baja Pipeline 47 eribulin mesylate 47 Bancorp NASDAQ EWBC 47 REYATAZ r 47 Lankenau Institute 47 interferon gamma 1b 47 Lawn herb garden 47 #mg/day [001] 47 Degarelix 47 Inc. Nasdaq EWBC 47 CML CP 47 RTOG 47 oral ridaforolimus 47 Relapsed Refractory 47 Phase 2a clinical 47 registrational trial 47 eritoran 47 lifts MASSACHUSETTS Berkshire 47 LymphoStat B belimumab 47 Beach Diet Cookbook 47 ug dose 47 Sequenced Treatment Alternatives 47 Eastern Region DONER 47 olaparib 47 HER2 expression 47 Myocardial Infarction Study 47 Brenda Wiegand Booth 47 null responder HCV 47 Response Evaluation Criteria 47 Katie Granquist 47 sunitinib Sutent 47 Ebola Vaccine 47 CTA# Injection 47 atypical Hemolytic Uremic Syndrome 47 multicentre 47 Moreira Gomes 47 nonmetastatic 47 HF ACTION 47 cytologically confirmed 47 Castration Resistant Prostate Cancer 47 Myocardial Infarction TIMI Study 47 cediranib 47 LHRH receptor positive 47 Cutaneous T 47 CIMZIA ™ 47 histone deacetylase HDAC inhibitor 47 vidofludimus 47 RECIST Response Evaluation Criteria 47 ORENCIA ® 47 nab paclitaxel 47 blinded randomized controlled 47 retrospective cohort study 47 paclitaxel poliglumex 47 metastatic colorectal 47 sorafenib Nexavar 47 Selects Allscripts 47 RoACTEMRA 47 Acquired Cardiovascular Disease 47 Intervention Effectiveness CATIE 47 NAACCR 47 APTIVUS R 47 hardline Wahhabi sect 47 candesartan cilexetil 47 Chappelle Show Comedy 47 Deerfield Ill. Takeda Pharmaceuticals 47 alfa 2a 47 PKC# 47 UTHSCT 47 PARTNER Trial 47 Black Skarn 47 NextLight Silver State 47 Translational Science Awards 47 phase IIb trial 47 Solid Tumors 47 regorafenib 47 estramustine 47 Dryland Agriculture 47 Allergy Cardiovascular 47 nonrandomized 47 plus prednisone 47 refractory cutaneous T 47 TCGA Pilot Project 47 cisplatin vinorelbine 47 PRE SURGE 47 insulin glulisine 47 Mermin oversees 47 QLT Plug Delivery 47 metastatic gastric 47 America originates transports 47 Multicenter AIDS 47 MedlinePlus Bird Flu 47 RE LY trial 47 pitavastatin 47 Phase 2b trial 46 unfractionated heparin UFH 46 dose melphalan 46 bronchial lavage 46 active comparator 46 sunitinib malate 46 Helps Predict 46 prucalopride 46 Inc. NASDAQ TSFG 46 collectively Hardwoods 46 Hepatocellular Carcinoma HCC 46 multicenter randomized placebo controlled 46 Sutus Business 46 vinca alkaloid 46 Corp. TSX PFN 46 Lung Injury 46 phase IIIb 46 Silgan operates 46 LEXIVA r 46 multicentre randomized double 46 Controlled Trial 46 Prostate Cancer Clinical Trial 46 Edmonton Cineplex Odeon 46 OBPM 46 Huntingdon Twp 46 multicentre prospective 46 GENTLE YOGA #:# 46 Epratuzumab 46 myelodysplastic myeloproliferative diseases 46 YERVOY 46 motesanib diphosphate 46 Randomised 46 Kiminobu Sugaya 46 blind multicenter 46 Mycophenolate Mofetil 46 FOLPI 46 hereditary medullary thyroid 46 ANIT 46 pertuzumab 46 HGS# 46 Guidelines Issued 46 Am J Manag 46 oral deforolimus 46 MORAb 46 pexelizumab trials 46 LUMINATE 46 stage IIIB 46 System USRDS 46 gastrointestinal stromal tumor GIST 46 Jack Pirozzolo 46 BCG refractory 46 trastuzumab emtansine T DM1 46 Endurant 46 Prospective Randomized Trial 46 radiolabeled TM# 46 J Clin Oncol 46 underwent resection 46 www.slcpl.org 46 Neurologic Disorders 46 AA Amyloidosis 46 fired shells southward 46 Alfa Wassermann SpA 46 Srikumar Chellappan 46 Ixempra 46 JANIE SMITH 46 Antibody Tests 46 iniparib BSI 46 Phase 2a trial 46 stage IIIA 46 Serdolect ® 46 prospectively defined 46 BY BLACKWELL THOMAS 46 HQK 46 talabostat 46 tenofovir emtricitabine 46 Meta analyzes 46 Afatinib 46 denileukin diftitox 46 AVONEX ® 46 Health Examination Survey 46 genotypic resistance 46 Soft Tissue Sarcoma 46 plus dexamethasone 46 K ras mutations 46 randomized placebo controlled 46 epoetin alpha 46 code Cu AA# 46 COPAXONE R 46 doripenem 46 Henni Espinosa ABS CBN 46 previously untreated follicular 46 darunavir r 46 relapsed refractory multiple myeloma 46 meta regression 46 ISEL 46 Berks Ramblers 46 somatostatin analog 46 Darrell Munro LL.B 46 cisplatin resistant 46 Translational Science Award 46 undetectable HBV DNA 46 clinical pharmacology studies 46 cancer mCRC 46 By Codell Rodriguez 46 Laryngeal Cancer 46 Aplidin 46 MAGE A3 46 cagA 46 WHO Collaborating Center 46 IL# PE#QQR 46 adecatumumab 46 Beverwyck Rd 46 hematopoietic cancers 46 ritonavir boosted 46 apremilast 46 Pulmonary Rehabilitation Program 46 protease inhibitor PI 46 Heartsaver classes 46 Drive Lisle IL 46 abacavir lamivudine 46 Taxotere ® 46 titrated glipizide 46 oral JAK#/JAK# inhibitor 46 Phase III randomized controlled 46 TAXUS IV 46 SORT OUT III 46 using PCA3 analyte 46 Institute www.dana farber.org 46 goalkeeper Ri Yong 46 prospectively randomized 45 journal Resuscitation 45 PROSTVAC ® 45 Gray avenues Wesleyville 45 Renal Associates 45 Cell Non Hodgkin 45 landmark ATHENA 45 Guo Tianyong professor 45 recurrent GBM 45 Exact Macola ERP 45 Ozarelix 45 Systemic Lupus Erythematosus SLE 45 By HEATHER McCRACKEN 45 Merck Suspends Lobbying 45 DRX# True Non 45 #-# sp index@standardandpoors.com 45 AGILECT R 45 liver transplant recipients 45 Data Registry NCDR 45 Malé Atoll 45 LandSkills 45 Mizner Boulevard 45 Abcourt Barvue project 45 refractory multiple myeloma 45 Hematopathology 45 Bruce Romanick 45 Vidofludimus 45 Motesanib 45 Koreans Na Yeon 45 pegylated liposomal doxorubicin 45 ascending dose 45 Phenoptin 45 conducted retrospective cohort 45 Costa Rica BCCR 45 Carfilzomib 45 heavily pretreated 45 Enteric Virus Surveillance 45 South Kivu provinces 45 metastatic malignant 45 mCi kg 45 MADIT CRT 45 CLIA accredited 45 visilizumab 45 PFN TSX PFN 45 Heterozygous Familial Hypercholesterolemia 45 Languages Mysore 45 nilotinib Tasigna 45 antibody MAb 45 perampanel 45 Advanced Renal Cell 45 Cloretazine 45 Tanespimycin 45 W. Stassney Lane 45 humanized interleukin 6 45 NeuroStar TMS Therapy 45 ® natalizumab 45 Phase III randomized 45 Chronic lymphocytic leukemia 45 brown baggers #x# 45 Body Composition Study 45 Nutrition Examination Surveys NHANES 45 posaconazole 45 limiting generalizability 45 OLD STEIN INN 45 prospective randomized controlled 45 Ongoing Planetarium 45 Borate Hills 45 Multicenter Study 45 Antiviral Therapy 45 Laboratories MRL 45 Onrigin 45 AEGR 45 Lung Cancer Trial 45 Data Base NCDB 45 Ocular Disease 45 Humac Laboratories 45 Breast Tumor 45 TORISEL 45 ISTODAX ® 45 lorvotuzumab mertansine 45 tumor histology 45 Kimbark Avenue 45 gemcitabine carboplatin 45 Mainframe BEA WebLogic BEA 45 velafermin 45 Evaluation Units VTEUs 45 Putt Corners Road 45 pain palliation 45 Kobokoto 45 Ryst Kuil 45 Surgeons Oncology 45 www.southparkstudios.com 45 Prevention CDC Morbidity 45 IFN alfa 45 KRAS status 45 Anne Polta West 45 Grille Sobik Subs 45 MIVI TRUST 45 DAS# CRP 45 superficial bladder cancer 45 YORK HOSPITAL 45 Excellence COBRE 45 plus COPEGUS 45 comparator arm 45 Arthroscopy Association 45 genomewide association study 45 SGS Lakefield Laboratories 45 ZD# [001] 45 prostate cancer CaP 45 Financial NASDAQ TSFG 45 Col. Ralph Kauzlarich 45 MabThera rituximab 45 Receiving Antenna 45 Simcoe Muskoka Local 45 mildly symptomatic 45 ABCSG 45 randomized multicentre 45 RSNA Radiological Society 45 melphalan prednisone 45 mCRC patients 45 reporter Denise Rockenstein 45 refractory NSCLC 45 Toru Kuzuhara president 45 mGluR5 negative 45 VITAL Trial 45 resected pancreatic cancer 45 Elsa Cardoso professor 45 atazanavir ritonavir 45 minimally symptomatic 45 mg kg Hematide 45 Glandular Disease Clinic 45 NATRECOR R 44 Forensic Sciences Laboratory CFSL 44 Decitabine 44 follicular lymphoma FL 44 Elacytarabine 44 formal pharmacokinetic PK 44 TRANSFORMS 44 controlled multicenter Phase 44 Solid Tumours 44 Ice Cen ter 44 By Tara Fasol 44 μg dose 44 TSX VENTURE FNR 44 refractory indolent non 44 TACI Ig 44 IPM Wound Gel 44 Institute EPRI 44 KRAS mutations occur 44 peritoneal cancer 44 Phase IIa trial 44 NHGRI Division 44 Pediatric Cardiac 44 chemist Domenico Chiovitti 44 Diffuse Large B 44 PHILLIPS GALLERY 44 gadobutrol 44 hA# 44 HuMax EGFr 44 histologies 44 Diabetes Fact Sheet 44 aplastic anemia AA 44 NIH registry www.clinicaltrials.gov 44 metastatic renal cell carcinoma 44 eosinophilic asthma 44 Kaptain Kenny 44 Centers 44 standard chemotherapy regimen 44 www.ceocentral.com 44 iii GTx 44 rALLy clinical trial 44 GCP compliant 44 Torisel 44 antitumor effect 44 Park SummerStage Rumsey 44 Chronic Lymphocytic Leukemia 44 PROSTVAC VF 44 small molecule Hedgehog 44 randomized blinded placebo 44 T1c 44 Dex Media Eliminations 44 AIDS Clinical Trials 44 Park Hamburgers Li'l 44 Post hoc 44 Toronto Burntsand 44 Communities ARIC study 44 Czura Thornton 44 • Kevin Kaduk 44 randomizing patients 44 CD# monoclonal antibody 44 www.ticketcentral.com 44 LAB CGRP 44 SERVICES OR ESTIMATES 44 Region DoNER 44 achieved sustained virologic 44 CIMZIA TM 44 postoperative chemotherapy 44 visit http:/www.clinicaltrials.gov/ 44 familial amyloidotic polyneuropathy FAP 44 patientswith 44 Cheshire Harriers 44 BRAF V#E 44 Hematologic 44 underwent liver transplantation 44 Kidney Disease Education 44 serum GGT 44 Company AMEX EML 44 visit http:/www.ibm.com/partnerworld 44 pegylated interferon alfa 2b 44 Childhood Asthma 44 adjacent Kemess 44 Follicular Lymphoma 44 tenofovir FTC 44 Physical Therapy PTJ 44 Thrombolysis 44 Pemetrexed 44 rapid virologic response 44 advanced unresectable 44 Geochemical analyzes 44 Carolina Utterly Awesome 44 Tyrima 44 Cambridge Mass. Endeca 44 adjuvant trastuzumab 44 sipuleucel T 44 Forensic Science Laboratory CFSL 44 biggest brewer AmBev 44 CORD II 44 SANTE 44 nonsmall cell lung cancer 44 sodium glucose cotransporter 44 Cholesterol Screening 44 NetShow formats 44 www.westpharma.com 44 histologic subtype 44 Kildonan Coun 44 Pregnancy Outcomes 44 Students Organisation NESO 44 commercialize RHUCIN 44 EUROCARE 44 selective modulator 44 BETHLEHEM TWP 44 dimeglumine 44 blind randomized 44 J Epidemiol Community 44 HGPIN 44 Irinotecan 44 th Massif 44 sporicidal product 44 Search PubMed Clinicaltrials.gov 44 Traficet EN 44 Foundation NSF NCAR 44 concurrent chemoradiation 44 Beltline NE 44 Cardiothoracic Anesthesia 44 Helps Smokers Quit 44 America www.pepsi.com 44 completely resected 44 examining VBLOC Therapy 44 COPAXONE ® 44 neoadjuvant 43 TMPRSS2 ERG 43 Assistive Technology Society 43 Toms River Intermediate 43 http:/www.menareport.com/ 43 darunavir ritonavir 43 Outpatient Mental Health 43 NABE Outlook 43 Oncomine 43 relapsing multiple sclerosis 43 Framingham Offspring 43 Kansas Uplift 43 CombAT study 43 InterSystems Ensemble ® 43 docetaxel chemotherapy 43 ritonavir boosted lopinavir 43 Interagency Coordinating Committee 43 Indiana REMC 43 ECOG 43 Johns Manville employs 43 HIVNET 43 Azacitidine 43 histologically confirmed 43 NLSY 43 mTOR mammalian target 43 SCIg 43 8mg/kg 43 oral Hycamtin 43 ovarian carcinoma 43 RhuDex ™ 43 chemotherapy cisplatin 43 bendamustine 43 NEVO 43 fluvastatin 43 histological subtypes 43 Dr. KM Cherian 43 HIV AIDS BC CfE 43 students Obamamania wanes 43 System EQUIS 43 panobinostat 43 Cloud Expo Cloud Expo 43 Betaferon ® 43 Estrogen Receptor 43 Projects Standardized 43 GCI Forex 43 Translational Science Institute 43 Respiratory Care NeuroCare 43 NHAMCS 43 randomized trials 43 Dasatinib 43 viral kinetics 43 F FDG PET 43 ATACAND 43 immunomodulatory therapy 43 dosing cohort